Literature DB >> 18202705

Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity.

K A Sedelies1, A Ciccone, C J P Clarke, J Oliaro, V R Sutton, F L Scott, J Silke, O Susanto, D R Green, R W Johnstone, P I Bird, J A Trapani, N J Waterhouse.   

Abstract

Human GraB (hGraB) preferentially induces apoptosis via Bcl-2-regulated mitochondrial damage but can also directly cleave caspases and caspase substrates in cell-free systems. How hGraB kills cells when it is delivered by cytotoxic lymphocytes (CL) and the contribution of hGraB to CL-induced death is still not clear. We show that primary human natural killer (hNK) cells, which specifically used hGraB to induce target cell death, were able to induce apoptosis of cells whose mitochondria were protected by Bcl-2. Purified hGraB also induced apoptosis of Bcl-2-overexpressing targets but only when delivered at 5- to 10-fold the concentration required to kill cells expressing endogenous Bcl-2. Caspases were critical in this process as inhibition of caspase activity permitted clonogenic survival of Bcl-2-overexpressing cells treated with hGraB or hNK cells but did not protect cells that only expressed endogenous Bcl-2. Our data therefore show that hGraB triggers caspase activation via mitochondria-dependent and mitochondria-independent mechanisms that are activated in a hierarchical manner, and that the combined effects of Bcl-2 and direct caspase inhibition can block cell death induced by hGraB and primary hNK cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202705     DOI: 10.1038/sj.cdd.4402300

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  16 in total

Review 1.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

2.  Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization.

Authors:  Daniella Brasacchio; Amber E Alsop; Tahereh Noori; Mariam Lufti; Sweta Iyer; Kaylene J Simpson; Phillip I Bird; Ruth M Kluck; Ricky W Johnstone; Joseph A Trapani
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

3.  Human NK cells activated by EBV+ lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.

Authors:  Diego Sánchez-Martínez; Gemma Azaceta; Aura Muntasell; Nacho Aguiló; David Núñez; Eva M Gálvez; Javier Naval; Alberto Anel; Luis Palomera; Carlos Vilches; Isabel Marzo; Martín Villalba; Julián Pardo
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

4.  Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis.

Authors:  O Susanto; S E Stewart; I Voskoboinik; D Brasacchio; M Hagn; S Ellis; S Asquith; K A Sedelies; P I Bird; N J Waterhouse; J A Trapani
Journal:  Cell Death Differ       Date:  2013-06-07       Impact factor: 15.828

5.  Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.

Authors:  Andreas Wortmann; Yaowu He; Melinda E Christensen; Mayla Linn; John W Lumley; Pamela M Pollock; Nigel J Waterhouse; John D Hooper
Journal:  J Biol Chem       Date:  2011-10-12       Impact factor: 5.157

6.  A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage.

Authors:  D Brasacchio; T Noori; C House; A J Brennan; K J Simpson; O Susanto; P I Bird; R W Johnstone; J A Trapani
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

7.  Granzyme M: characterization with sites of post-translational modification and specific sites of interaction with substrates and inhibitors.

Authors:  Rukhshan Khurshid; Mahjabeen Saleem; Muhammad Saleem Akhtar; Asmat Salim
Journal:  Mol Biol Rep       Date:  2010-01-28       Impact factor: 2.316

8.  Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737.

Authors:  V R Sutton; K Sedelies; G Dewson; M E Christensen; P I Bird; R W Johnstone; R M Kluck; J A Trapani; N J Waterhouse
Journal:  Cell Death Dis       Date:  2012-07-05       Impact factor: 8.469

9.  In vivo elimination of MHC-I-deficient lymphocytes by activated natural killer cells is independent of granzymes A and B.

Authors:  Matthias Regner; Lisa Pavlinovic; Nicolie Young; Arno Müllbacher
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

10.  Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression.

Authors:  Sanket Joshi; Antony W Braithwaite; Phillip J Robinson; Megan Chircop
Journal:  Mol Cancer       Date:  2011-06-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.